Colgate-Palmolive (NYSE:CL) Shares Sold by Deseret Mutual Benefit Administrators

Deseret Mutual Benefit Administrators cut its position in Colgate-Palmolive (NYSE:CL) by 2.4% during the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 4,897 shares of the company’s stock after selling 119 shares during the quarter. Deseret Mutual Benefit Administrators’ holdings in Colgate-Palmolive were worth $508,000 at the end of the most recent quarter.

Several other large investors also recently made changes to their positions in CL. Price T Rowe Associates Inc. MD boosted its stake in shares of Colgate-Palmolive by 27.8% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 41,067,130 shares of the company’s stock worth $3,698,096,000 after acquiring an additional 8,933,912 shares in the last quarter. Swedbank AB acquired a new stake in shares of Colgate-Palmolive during the first quarter valued at approximately $286,370,000. Acadian Asset Management LLC increased its holdings in shares of Colgate-Palmolive by 108.4% in the 2nd quarter. Acadian Asset Management LLC now owns 5,682,280 shares of the company’s stock valued at $551,367,000 after purchasing an additional 2,955,442 shares during the period. Massachusetts Financial Services Co. MA raised its holdings in shares of Colgate-Palmolive by 40.7% during the second quarter. Massachusetts Financial Services Co. MA now owns 8,969,498 shares of the company’s stock worth $870,400,000 after acquiring an additional 2,593,313 shares in the last quarter. Finally, Ossiam raised its stake in shares of Colgate-Palmolive by 368.4% during the 1st quarter. Ossiam now owns 1,563,768 shares of the company’s stock worth $140,817,000 after purchasing an additional 1,229,891 shares in the last quarter. Institutional investors and hedge funds own 80.41% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms have commented on CL. Barclays boosted their target price on shares of Colgate-Palmolive from $91.00 to $96.00 and gave the stock an “equal weight” rating in a research report on Monday, July 29th. Hsbc Global Res lowered shares of Colgate-Palmolive from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 26th. TD Cowen decreased their target price on Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating for the company in a research note on Monday, October 28th. Bank of America upped their price target on Colgate-Palmolive from $100.00 to $110.00 and gave the stock a “buy” rating in a report on Wednesday, July 10th. Finally, Sanford C. Bernstein boosted their target price on shares of Colgate-Palmolive from $100.00 to $103.00 and gave the stock a “market perform” rating in a research report on Tuesday, July 30th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $105.11.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $90.16 on Thursday. The stock has a market cap of $73.66 billion, a price-to-earnings ratio of 25.85, a P/E/G ratio of 3.33 and a beta of 0.42. Colgate-Palmolive has a 12-month low of $74.67 and a 12-month high of $109.30. The company has a quick ratio of 0.68, a current ratio of 1.04 and a debt-to-equity ratio of 9.46. The business’s 50-day simple moving average is $101.49 and its 200 day simple moving average is $98.39.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be given a $0.50 dividend. The ex-dividend date is Friday, October 18th. This represents a $2.00 annualized dividend and a dividend yield of 2.22%. Colgate-Palmolive’s dividend payout ratio is currently 57.31%.

Insider Activity at Colgate-Palmolive

In related news, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the sale, the director now directly owns 11,755 shares of the company’s stock, valued at approximately $1,220,874.30. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.37% of the stock is currently owned by corporate insiders.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.